Extract from the Register of European Patents

EP Legal status: EP2170886

Designated contracting statesAT 
BE 
BG 
CH 
CY 
CZ 
DE 
DK 
EE 
ES 
FI 
FR 
GB 
GR 
HR 
HU 
IE 
IS 
IT 
LI 
LT 
LU 
LV 
MC 
MT 
NL 
NO 
PL 
PT 
RO 
SE 
SI 
SK 
TR 
Examination procedure14.03.2012Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2012/31]
Entry into regional phase25.01.2010National basic fee paid 
25.01.2010Designation fee(s) paid 
25.01.2010Examination fee paid 
Fees paidRenewal fee
26.01.2011Renewal fee patent year 03
05.01.2012Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.07.201003   M06   Fee paid on   26.01.2011
31.07.201104   M06   Fee paid on   05.01.2012
INPADOC data   TooltipThe EPO does not accept any responsibility for the accuracy of legal status data relating to the post-grant phase, including but not limited to their completeness and fitness for specific purposes, nor can it guarantee that such data are up to date. For authoritative information, please refer to the relevant national patent authority.
Event date:07.04.2010 
Event description:REQUEST FOR EXAMINATION FILED
Effective DATE:20100125
 
Event date:07.04.2010 
Event description:DESIGNATED CONTRACTING STATES
Kind Code of Ref Document:A1
Designated State(s):AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
 
Event date:07.04.2010 
Event description:REQUEST FOR EXTENSION OF THE EUROPEAN PATENT
Countries concerned:AL BA MK RS
 
Event date:06.10.2010 
Event description:REQUEST FOR EXTENSION OF THE EUROPEAN PATENT (DELETED)
 
Event date:20.10.2010 
Event description:FIRST EXAMINATION REPORT DESPATCHED
Effective DATE:20100916
 
Event date:20.07.2011 
Event description:PARTY DATA CHANGED (APPLICANT DATA CHANGED OR RIGHTS OF AN APPLICATION TRANSFERRED)
OWNER:CANCER RESEARCH TECHNOLOGY LIMITED
 
Event date:28.09.2011 
Event description:TITLE (CORRECTION)
Free Format Text:9H-PYRIMIDO(4',3':4,5)PYRROLO(2,3-D)PYRIDINES, AND 9H-1,3,6,9-TETRAAZA-FLUORENES AS CHK1 KINASE FUNCTION INHIBITORS
 
Event date:01.08.2012 
Event description:APPLICATION DEEMED TO BE WITHDRAWN
Effective DATE:20120204
 
Event date:12.09.2011 
Event description:DESPATCH OF COMMUNICATION OF INTENTION TO GRANT A PATENT
Free Format Text:ORIGINAL CODE: EPIDOSNIGR1
 
Event date:05.03.2010 
Event description:PUBLIC REFERENCE MADE UNDER ARTICLE 153(3) EPC TO A PUBLISHED INTERNATIONAL APPLICATION THAT HAS ENTERED THE EUROPEAN PHASE
Free Format Text:ORIGINAL CODE: 0009012
 
Event date:29.06.2012 
Event description:INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT
Free Format Text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN